Switch to:
Also traded in: Germany

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 8/10

vs
industry
vs
history
Cash to Debt 1.58
ADUS's Cash to Debt is ranked higher than
69% of the 243 Companies
in the Global Medical Care industry.

( Industry Median: 0.34 vs. ADUS: 1.58 )
Ranked among companies with meaningful Cash to Debt only.
ADUS' s Cash to Debt Range Over the Past 10 Years
Min: 0.01  Med: 0.44 Max: No Debt
Current: 1.58
Equity to Asset 0.65
ADUS's Equity to Asset is ranked higher than
74% of the 241 Companies
in the Global Medical Care industry.

( Industry Median: 0.48 vs. ADUS: 0.65 )
Ranked among companies with meaningful Equity to Asset only.
ADUS' s Equity to Asset Range Over the Past 10 Years
Min: 0.25  Med: 0.61 Max: 0.74
Current: 0.65
0.25
0.74
Interest Coverage 5.23
ADUS's Interest Coverage is ranked lower than
63% of the 218 Companies
in the Global Medical Care industry.

( Industry Median: 7.64 vs. ADUS: 5.23 )
Ranked among companies with meaningful Interest Coverage only.
ADUS' s Interest Coverage Range Over the Past 10 Years
Min: 1.02  Med: 5.12 Max: 25.89
Current: 5.23
1.02
25.89
F-Score: 5
Z-Score: 5.56
M-Score: -2.91
WACC vs ROIC
1.23%
5.94%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 7/10

vs
industry
vs
history
Operating margin (%) 2.77
ADUS's Operating margin (%) is ranked lower than
73% of the 244 Companies
in the Global Medical Care industry.

( Industry Median: 7.23 vs. ADUS: 2.77 )
Ranked among companies with meaningful Operating margin (%) only.
ADUS' s Operating margin (%) Range Over the Past 10 Years
Min: 2.59  Med: 4.76 Max: 6.41
Current: 2.77
2.59
6.41
Net-margin (%) 2.04
ADUS's Net-margin (%) is ranked lower than
69% of the 244 Companies
in the Global Medical Care industry.

( Industry Median: 4.95 vs. ADUS: 2.04 )
Ranked among companies with meaningful Net-margin (%) only.
ADUS' s Net-margin (%) Range Over the Past 10 Years
Min: -0.86  Med: 2.62 Max: 7.2
Current: 2.04
-0.86
7.2
ROE (%) 5.40
ADUS's ROE (%) is ranked lower than
70% of the 229 Companies
in the Global Medical Care industry.

( Industry Median: 10.69 vs. ADUS: 5.40 )
Ranked among companies with meaningful ROE (%) only.
ADUS' s ROE (%) Range Over the Past 10 Years
Min: -10.67  Med: 7.15 Max: 18.38
Current: 5.4
-10.67
18.38
ROA (%) 3.57
ADUS's ROA (%) is ranked lower than
56% of the 246 Companies
in the Global Medical Care industry.

( Industry Median: 4.67 vs. ADUS: 3.57 )
Ranked among companies with meaningful ROA (%) only.
ADUS' s ROA (%) Range Over the Past 10 Years
Min: -1.23  Med: 3.67 Max: 12.2
Current: 3.57
-1.23
12.2
ROC (Joel Greenblatt) (%) 15.46
ADUS's ROC (Joel Greenblatt) (%) is ranked lower than
57% of the 246 Companies
in the Global Medical Care industry.

( Industry Median: 21.13 vs. ADUS: 15.46 )
Ranked among companies with meaningful ROC (Joel Greenblatt) (%) only.
ADUS' s ROC (Joel Greenblatt) (%) Range Over the Past 10 Years
Min: 15.46  Med: 27.97 Max: 43.85
Current: 15.46
15.46
43.85
Revenue Growth (3Y)(%) 9.90
ADUS's Revenue Growth (3Y)(%) is ranked higher than
61% of the 175 Companies
in the Global Medical Care industry.

( Industry Median: 7.70 vs. ADUS: 9.90 )
Ranked among companies with meaningful Revenue Growth (3Y)(%) only.
ADUS' s Revenue Growth (3Y)(%) Range Over the Past 10 Years
Min: -54.8  Med: -17.4 Max: 9.9
Current: 9.9
-54.8
9.9
EBITDA Growth (3Y)(%) 2.90
ADUS's EBITDA Growth (3Y)(%) is ranked lower than
61% of the 152 Companies
in the Global Medical Care industry.

( Industry Median: 6.70 vs. ADUS: 2.90 )
Ranked among companies with meaningful EBITDA Growth (3Y)(%) only.
ADUS' s EBITDA Growth (3Y)(%) Range Over the Past 10 Years
Min: -52.9  Med: -16 Max: 8.2
Current: 2.9
-52.9
8.2
EPS Growth (3Y)(%) 5.90
ADUS's EPS Growth (3Y)(%) is ranked lower than
53% of the 130 Companies
in the Global Medical Care industry.

( Industry Median: 6.80 vs. ADUS: 5.90 )
Ranked among companies with meaningful EPS Growth (3Y)(%) only.
ADUS' s EPS Growth (3Y)(%) Range Over the Past 10 Years
Min: 5.9  Med: 11.5 Max: 35.1
Current: 5.9
5.9
35.1
GuruFocus has detected 3 Warning Signs with Addus HomeCare Corp $ADUS.
More than 500,000 people have already joined GuruFocus to track the stocks they follow and exchange investment ideas.
» ADUS's 10-Y Financials

Financials (Next Earnings Date: 2017-03-06)


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow
Oprt. Cash Flow & Net Income

» Details

Guru Trades

Q1 2016

ADUS Guru Trades in Q1 2016

Chuck Royce Sold Out
Jim Simons 133,500 sh (-14.75%)
» More
Q2 2016

ADUS Guru Trades in Q2 2016

Jim Simons 84,200 sh (-36.93%)
» More
Q3 2016

ADUS Guru Trades in Q3 2016

Jim Simons 50,100 sh (-40.50%)
» More
Q4 2016

ADUS Guru Trades in Q4 2016

Jim Simons 12,300 sh (-75.45%)
» More
» Details

Insider Trades

Latest Guru Trades with ADUS

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Business Description

Industry: Health Care Providers » Medical Care    NAICS: 621610    SIC: 8082
Compare:OTCPK:CMBGF, OTCPK:MFCSF, OTCPK:RLGHF, NAS:AFAM, NYSE:QHC, NYSE:CCM, NAS:PRSC, NYSE:AAC, NAS:BIOS, AMEX:HLTH, NYSE:ADPT, OTCPK:CATS, OTCPK:AMEH, OTCPK:MIHI, NAS:JYNT, OTCPK:FCHS, OTCPK:CCEL, OTCPK:BNKL, AMEX:AMS, AMEX:SSY » details
Traded in other countries:A41.Germany,
Addus HomeCare Corp provides home and community based services, which are mainly social in nature and are provided in the home, focused on the dual eligible population.

Addus HomeCare Corp was incorporated in Delaware in 2006 under the name Addus Holding Corporation for the purpose of acquiring Addus HealthCare, Inc. The Company provides home and community based services, which are mainly social in nature and are provided in the home, focused on the dual eligible population. Its services include personal care and assistance with activities of daily living, and adult day care. Its consumers are individuals with special needs who are at risk of hospitalization or institutionalization, such as the elderly, chronically ill and disabled. Its payor clients include federal, state and local governmental agencies, commercial insurers and private individuals. It provides home and community based services through over 121 locations across 21 states to over 26,000 consumers. The home and community based services the company provides are mainly social in nature and include assistance with bathing, grooming, dressing, personal hygiene and medication reminders, and other activities of daily living. It provides these services on a long-term, continuous basis, with an average duration of approximately 17 months per consumer. Its adult day centers provide a comprehensive program of skilled and support services and designated medical services for adults in a community-based group setting. Services provided by Company's adult day centers include social activities, transportation services to and from the centers, the provision of meals and snacks, personal care and therapeutic activities such as exercise and cognitive interaction. The Company competes with home and community based service providers, home health providers, private caregivers, larger publicly held companies, privately held companies, privately held single-site agencies, hospital-based agencies, not-for-profit organizations, community-based organizations, managed care organizations and self-directed care programs. Its business is subject to extensive and increasing federal, state and local regulation.

Ratios

vs
industry
vs
history
P/E(ttm) 49.22
ADUS's P/E(ttm) is ranked lower than
78% of the 221 Companies
in the Global Medical Care industry.

( Industry Median: 25.24 vs. ADUS: 49.22 )
Ranked among companies with meaningful P/E(ttm) only.
ADUS' s P/E(ttm) Range Over the Past 10 Years
Min: 4.55  Med: 20.59 Max: 51.74
Current: 49.22
4.55
51.74
Forward P/E 21.79
ADUS's Forward P/E is ranked lower than
59% of the 76 Companies
in the Global Medical Care industry.

( Industry Median: 20.20 vs. ADUS: 21.79 )
Ranked among companies with meaningful Forward P/E only.
N/A
PE(NRI) 51.44
ADUS's PE(NRI) is ranked lower than
82% of the 196 Companies
in the Global Medical Care industry.

( Industry Median: 26.44 vs. ADUS: 51.44 )
Ranked among companies with meaningful PE(NRI) only.
ADUS' s PE(NRI) Range Over the Past 10 Years
Min: 2.97  Med: 21.1 Max: 54.09
Current: 51.44
2.97
54.09
Price/Owner Earnings (ttm) 31.12
ADUS's Price/Owner Earnings (ttm) is ranked lower than
59% of the 93 Companies
in the Global Medical Care industry.

( Industry Median: 27.99 vs. ADUS: 31.12 )
Ranked among companies with meaningful Price/Owner Earnings (ttm) only.
ADUS' s Price/Owner Earnings (ttm) Range Over the Past 10 Years
Min: 0.79  Med: 17.16 Max: 295.9
Current: 31.12
0.79
295.9
P/B 2.58
ADUS's P/B is ranked higher than
53% of the 253 Companies
in the Global Medical Care industry.

( Industry Median: 2.73 vs. ADUS: 2.58 )
Ranked among companies with meaningful P/B only.
ADUS' s P/B Range Over the Past 10 Years
Min: 0.38  Med: 1.44 Max: 3.02
Current: 2.58
0.38
3.02
P/S 1.00
ADUS's P/S is ranked higher than
68% of the 256 Companies
in the Global Medical Care industry.

( Industry Median: 1.67 vs. ADUS: 1.00 )
Ranked among companies with meaningful P/S only.
ADUS' s P/S Range Over the Past 10 Years
Min: 0.07  Med: 0.59 Max: 1.32
Current: 1
0.07
1.32
PFCF 16.17
ADUS's PFCF is ranked higher than
70% of the 115 Companies
in the Global Medical Care industry.

( Industry Median: 23.76 vs. ADUS: 16.17 )
Ranked among companies with meaningful PFCF only.
ADUS' s PFCF Range Over the Past 10 Years
Min: 1.25  Med: 10.5 Max: 154.97
Current: 16.17
1.25
154.97
POCF 14.88
ADUS's POCF is ranked lower than
52% of the 168 Companies
in the Global Medical Care industry.

( Industry Median: 14.75 vs. ADUS: 14.88 )
Ranked among companies with meaningful POCF only.
ADUS' s POCF Range Over the Past 10 Years
Min: 1.24  Med: 10.92 Max: 92.2
Current: 14.88
1.24
92.2
EV-to-EBIT 34.84
ADUS's EV-to-EBIT is ranked lower than
79% of the 206 Companies
in the Global Medical Care industry.

( Industry Median: 20.76 vs. ADUS: 34.84 )
Ranked among companies with meaningful EV-to-EBIT only.
ADUS' s EV-to-EBIT Range Over the Past 10 Years
Min: -11.5  Med: 11.3 Max: 36.6
Current: 34.84
-11.5
36.6
EV-to-EBITDA 21.05
ADUS's EV-to-EBITDA is ranked lower than
68% of the 222 Companies
in the Global Medical Care industry.

( Industry Median: 15.90 vs. ADUS: 21.05 )
Ranked among companies with meaningful EV-to-EBITDA only.
ADUS' s EV-to-EBITDA Range Over the Past 10 Years
Min: -23.9  Med: 9.5 Max: 22.1
Current: 21.05
-23.9
22.1
PEG 8.02
ADUS's PEG is ranked lower than
82% of the 79 Companies
in the Global Medical Care industry.

( Industry Median: 2.80 vs. ADUS: 8.02 )
Ranked among companies with meaningful PEG only.
ADUS' s PEG Range Over the Past 10 Years
Min: 0  Med: 0 Max: N/A
Current: 8.02
Current Ratio 2.64
ADUS's Current Ratio is ranked higher than
84% of the 238 Companies
in the Global Medical Care industry.

( Industry Median: 1.29 vs. ADUS: 2.64 )
Ranked among companies with meaningful Current Ratio only.
ADUS' s Current Ratio Range Over the Past 10 Years
Min: 1.68  Med: 2.2 Max: 2.99
Current: 2.64
1.68
2.99
Quick Ratio 2.64
ADUS's Quick Ratio is ranked higher than
86% of the 238 Companies
in the Global Medical Care industry.

( Industry Median: 1.15 vs. ADUS: 2.64 )
Ranked among companies with meaningful Quick Ratio only.
ADUS' s Quick Ratio Range Over the Past 10 Years
Min: 1.68  Med: 2.2 Max: 2.99
Current: 2.64
1.68
2.99
Days Sales Outstanding 76.92
ADUS's Days Sales Outstanding is ranked lower than
86% of the 204 Companies
in the Global Medical Care industry.

( Industry Median: 42.10 vs. ADUS: 76.92 )
Ranked among companies with meaningful Days Sales Outstanding only.
ADUS' s Days Sales Outstanding Range Over the Past 10 Years
Min: 76.05  Med: 92.07 Max: 114.79
Current: 76.92
76.05
114.79
Days Payable 5.52
ADUS's Days Payable is ranked lower than
92% of the 157 Companies
in the Global Medical Care industry.

( Industry Median: 39.14 vs. ADUS: 5.52 )
Ranked among companies with meaningful Days Payable only.
ADUS' s Days Payable Range Over the Past 10 Years
Min: 5.52  Med: 7.52 Max: 11.4
Current: 5.52
5.52
11.4

Buy Back

vs
industry
vs
history
3-Year Average Share Buyback Ratio -0.90
ADUS's 3-Year Average Share Buyback Ratio is ranked higher than
69% of the 121 Companies
in the Global Medical Care industry.

( Industry Median: -2.50 vs. ADUS: -0.90 )
Ranked among companies with meaningful 3-Year Average Share Buyback Ratio only.
ADUS' s 3-Year Average Share Buyback Ratio Range Over the Past 10 Years
Min: -119.5  Med: -0.95 Max: -0.5
Current: -0.9
-119.5
-0.5

Valuation & Return

vs
industry
vs
history
Price/Net Current Asset Value 7.33
ADUS's Price/Net Current Asset Value is ranked higher than
58% of the 69 Companies
in the Global Medical Care industry.

( Industry Median: 8.92 vs. ADUS: 7.33 )
Ranked among companies with meaningful Price/Net Current Asset Value only.
ADUS' s Price/Net Current Asset Value Range Over the Past 10 Years
Min: 1.85  Med: 5.73 Max: 26.29
Current: 7.33
1.85
26.29
Price/Tangible Book 6.49
ADUS's Price/Tangible Book is ranked lower than
73% of the 200 Companies
in the Global Medical Care industry.

( Industry Median: 4.09 vs. ADUS: 6.49 )
Ranked among companies with meaningful Price/Tangible Book only.
ADUS' s Price/Tangible Book Range Over the Past 10 Years
Min: 1.39  Med: 4.47 Max: 12.07
Current: 6.49
1.39
12.07
Price/Projected FCF 1.21
ADUS's Price/Projected FCF is ranked higher than
71% of the 99 Companies
in the Global Medical Care industry.

( Industry Median: 1.79 vs. ADUS: 1.21 )
Ranked among companies with meaningful Price/Projected FCF only.
ADUS' s Price/Projected FCF Range Over the Past 10 Years
Min: 0.84  Med: 1.13 Max: 1.65
Current: 1.21
0.84
1.65
Price/Median PS Value 1.70
ADUS's Price/Median PS Value is ranked lower than
84% of the 227 Companies
in the Global Medical Care industry.

( Industry Median: 1.03 vs. ADUS: 1.70 )
Ranked among companies with meaningful Price/Median PS Value only.
ADUS' s Price/Median PS Value Range Over the Past 10 Years
Min: 0.15  Med: 0.93 Max: 2.07
Current: 1.7
0.15
2.07
Price/Graham Number 3.85
ADUS's Price/Graham Number is ranked lower than
74% of the 152 Companies
in the Global Medical Care industry.

( Industry Median: 2.39 vs. ADUS: 3.85 )
Ranked among companies with meaningful Price/Graham Number only.
ADUS' s Price/Graham Number Range Over the Past 10 Years
Min: 0.49  Med: 1.89 Max: 3.92
Current: 3.85
0.49
3.92
Earnings Yield (Greenblatt) (%) 2.84
ADUS's Earnings Yield (Greenblatt) (%) is ranked lower than
64% of the 257 Companies
in the Global Medical Care industry.

( Industry Median: 3.90 vs. ADUS: 2.84 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) (%) only.
ADUS' s Earnings Yield (Greenblatt) (%) Range Over the Past 10 Years
Min: 2.7  Med: 8.55 Max: 44.4
Current: 2.84
2.7
44.4

More Statistics

Revenue (TTM) (Mil) $381.8
EPS (TTM) $ 0.69
Beta-0.18
Short Percentage of Float2.63%
52-Week Range $15.33 - 36.40
Shares Outstanding (Mil)11.46

Analyst Estimate

Dec16 Dec17 Dec18
Revenue (Mil $) 401 430 451
EPS ($) 1.34 1.58 1.76
EPS w/o NRI ($) 1.34 1.58 1.76
EPS Growth Rate
(3Y to 5Y Estimate)
15.00%
Dividends Per Share ($)
» More Articles for ADUS

Headlines

Articles On GuruFocus.com
100 Stocks at All-Time Highs | 60 Dividend Stocks Below the Results Feb 19 2013 

More From Other Websites
Addus Homecare Announces Fourth Quarter and Year-End 2016 Earnings Release and Conference Call Feb 13 2017
Addus HomeCare Corp. – Value Analysis (NASDAQ:ADUS) : January 23, 2017 Jan 23 2017
Addus HomeCare Corp. breached its 50 day moving average in a Bearish Manner : ADUS-US : January 20,... Jan 20 2017
ADDUS HOMECARE CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Change in... Jan 18 2017
Luminex Projects Strong Q4 Revenues, Issues 2017 Guidance Jan 11 2017
PerkinElmer (PKI) to Acquire India-Based Tulip Diagnostics Jan 10 2017
Allscripts (MDRX) Q4 Bookings Likely to Hit Record Levels Jan 10 2017
Air Methods (AIRM): Winter Hits December Passenger Count Jan 09 2017
AngioDynamics (ANGO) Beats Q2 Earnings, Lifts 2017 View Jan 09 2017
Cerner Extends HNM Partnership with University of Missouri Jan 06 2017
Alere Forensic Toxicology Division Gets ABFT Accreditation Jan 06 2017
Luminex (LMNX) Gets FDA Clearance for ARIES GBS Assay Jan 05 2017
Mazor Robotics (MZOR) Receives 21 System Orders in Q4 Jan 05 2017
ADDUS HOMECARE CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Change in... Jan 04 2017
Cerner Hurt by Low System Sales and Intense Competition Jan 04 2017
Natus Medical Closes GN Otometrics Business Acquisition Jan 04 2017
Patterson Companies Hurt by Competition & Integration Risks Jan 04 2017
Addus HomeCare Appoints Brad Bickham to Post of Executive Vice President - Chief Operating Officer Jan 04 2017
Addus HomeCare Appoints Brad Bickham to Post of Executive Vice President - Chief Operating Officer Jan 04 2017
Neogen (NEOG) Acquires Brazilian Private Company Rogama Dec 28 2016

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)